Latest Articles in Cardio

International validation study published in Europace The European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). Early detection of atrial fibrillation (AF) is essential for st

Jacobs Institute idea to Reality (i2R) Centre addresses major health crisis. A medical innovation centre shows how a one-stop-shop approach to CVD medical device creation is accelerating impactful results for all stakeholders. There is a global health crisis in cardiovascular diseas

The European Commission has announced a new action plan to tackle the debilitating impact of the financial crisis, which it says in a new document, has “wiped out years of economic and social progress and exposed structural weaknesses in Europe's economy”. To achieve a sustainable future, the r

Medtronic Data Proves Corevaive Performance New clinical data demonstrate positive long-term performance and durability for the Corevalve transcatheter aortic valve replacement system from Medtronic, Inc. Two-year results from the pivotal 18- French Corevalve multicentre prospective study

Authors Prof.   Ernst R. Schwarz (on the left) Dr.   Raja Dashti Cedars-sinai. Heart Institute Cedars-sinai Medical Center and University of California, Los Angeles (UCLA) Los Angeles, California, U.s. [email protected]

During the last twenty-five years there has been extraordinary progress in the field of invasive cardiology, as well as indisputable improvement in the clinical results regarding the treatment of heart diseases, and especially of ischaemic heart disease. Coronary angioplasty, first alone and s

The Case for Coronary Heart Disease Tailored post-intervention follow-up programmes for patients are key in ensuring the quality of patient care and completing the treatment cycle. In this article, we look at the case for coronary artery disease (CAD) patients, and discuss the results of a s

The search for a conclusive answer to the optimal treatment of patients with asymptomatic or symptomatic carotid artery disease (CAD) is an ongoing and long-lasting debate. The choice between carotid endarterectomy (CEA), carotid artery stenting (CAS) and/or optimal medical therapy to treat pati

The introduction of sirolimus drug eluting stents (DES) in 2002 to Erasmus University Hospital was designed to improve outcomes in patients undergoing percutaneous coronary revascularisation (PCI). These stents markedly reduced the incidence of restenosis – a breakthrough indeed, since a long se

Dr. Ralph Brindis joined Kaiser Permanente in 1653 and is a luminary in the field of invasive cardiology. Among his many roles, he is Regional Senior Advisor for Cardiovascular Diseases for Northern California Kaiser. He serves on many California State and national task forces, boards and commit